Marrone Bio Innov (MBII)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2016 | 12-2015 | 12-2014 | 12-2013 | 12-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -31,071 | -43,728 | -51,659 | -31,242 | -38,794 |
| Depreciation Amortization | 2,235 | 3,510 | 2,591 | 994 | 613 |
| Accounts receivable | -1,245 | -560 | 2,900 | -1,717 | -2,523 |
| Accounts payable and accrued liabilities | -588 | -3,486 | 1,667 | 1,682 | 1,174 |
| Other Working Capital | 396 | -531 | 7,555 | -3,896 | -2,446 |
| Other Operating Activity | 5,966 | 8,621 | 1,011 | 115 | 19,551 |
| Operating Cash Flow | $-24,307 | $-36,174 | $-35,935 | $-34,064 | $-22,425 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | 13,667 | -13,695 | 2,000 |
| PPE Investments | -209 | -1,646 | -12,996 | -3,925 | -2,757 |
| Investing Cash Flow | $-209 | $-1,646 | $671 | $-17,620 | $-757 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 39,698 | 14,383 | 13,109 | 41,951 |
| Debt Repayment | -1,081 | -2,418 | -6,138 | -12,542 | -1,863 |
| Common Stock Issued | 31 | 54 | 41,304 | 56,380 | 24 |
| Other Financing Activity | 15,337 | -15,000 | -3,416 | 9,186 | -9,139 |
| Financing Cash Flow | $14,287 | $22,334 | $46,133 | $66,133 | $30,973 |
| Beginning Cash Position | 19,838 | 35,324 | 24,455 | 10,006 | 2,215 |
| End Cash Position | 9,609 | 19,838 | 35,324 | 24,455 | 10,006 |
| Net Cash Flow | $-10,229 | $-15,486 | $10,869 | $14,449 | $7,791 |
| Free Cash Flow | |||||
| Operating Cash Flow | -24,307 | -36,174 | -35,935 | -34,064 | -22,425 |
| Capital Expenditure | -209 | -1,653 | -13,002 | -3,966 | -2,757 |
| Free Cash Flow | -24,516 | -37,827 | -48,937 | -38,030 | -25,182 |